Assessment of Tunisian clays for their potential application as excipient in pharmaceutical preparations: 2-amino-5-chlorobenzophenone adsorption
Source abstract
Abstract
The objective of this manuscript was to test the drug-loading and delivery properties of Tunisian clays to demonstrate their potential as low-cost excipients in pharmaceutical formulations. Raw kaolinite, purified smectite, and organophilic smectite were studied for the adsorption and desorption of 2-amino-5-chlorobenzophenone (2A-5BC) as a drug model molecule. The adsorption and desorption properties of these clay samples were investigated under different pH conditions, including those emulating the intestinal and gastric fluids from human body. DFT calculations were performed to characterize the atomic interactions involved in the adsorption mechanism. The adsorption and desorption properties of these clays were correlated with their main physicochemical properties and textural parameters. The maximum 2A-5BC adsorption (i.e., 48.2 mg/g) was achieved using smectite functionalized with HDTMA. Electrostatic forces and hydrogen bonds played a relevant role during 2A-5BC adsorption. The desorption of 2A-5BC from clay samples was effective at 37 °C and pH similar to the intestinal and gastric fluids, thus reaching desorption efficiencies of up to 93%. 2A-5BC desorption data were modeled with the Korsmeyer-Peppas equation and the results indicated the presence of a non-Fickian mass transport. Tunisian smectite functionalized with HDTMA presented promising performance and can be considered as a potential excipient in pharmaceutical formulations.
Source: openaire · Quality: candidate unverified · Source record ↗
Research context
OpenAlex topics: Clay minerals and soil interactions · Therapeutic Uses of Natural Elements · Layered Double Hydroxides Synthesis and Applications
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
References (68)
Show source-provided references
1. Suitability of a Miocene bentonite from North Western Desert of Egypt for pharmaceutical use10.1016/j.clay.2011.02.012 ↗
2. Suitability of a Miocene bentonite from North Western Desert of Egypt for pharmaceutical use10.1016/j.clay.2011.02.012 ↗
3. Calculation of adsorption isotherms by statistical physics models: a review10.1007/s10311-021-01279-8 ↗
4. 1963
5. Modification of bentonite with cationic and nonionic surfactants: structural and textural features10.3390/ma12223772 ↗
6. Synthesis, characterization, cellular uptake and cytotoxicity of a multi-functional magnetic nanocomposite for the targeted delivery and controlled release of doxorubicin to cancer cells10.1039/c2jm31794j ↗
7. Synthesis and characterization of montmorillonite/N-(carboxyacyl) chitosan coated magnetic particle nanocomposites for controlled delivery of paracetamol10.1016/j.clay.2013.11.039 ↗
8. Flow and tableting behaviors of some Egyptian kaolin powders as potential pharmaceutical excipients10.3390/min10010023 ↗
9. CEC of clays: measurement by adsorption of a copper ethylenediamine complex10.1016/S0169-1317(97)00012-4 ↗
10. Rietveld refinement of non-hydrogen atomic positions in kaolinite10.1346/CCMN.1989.0370401 ↗
11. Adsorption behavior of radioiodides in hexadecylpyridinium–humate complexes10.1016/S0169-1317(01)00060-6 ↗
12. Adsorption removal of humic acid from water using a modified Algerian bentonite
13. Clay and non-clay minerals in the pharmaceutical industry10.1016/j.clay.2009.07.017 ↗
14. Clay and non-clay minerals in the pharmaceutical and cosmetic industries Part II. Active ingredients10.1016/j.clay.2009.10.016 ↗
15. Adsorption of Cr(VI) in aqueous solution using a surfactant-modified bentonite10.1155/2020/3628163 ↗
16. Thiabendazole/bentonites hybrids as controlled release systems10.1016/j.colsurfb.2018.12.030 ↗
17. Some properties of thermal muds of some spas in Turkey10.1016/j.clay.2010.02.005 ↗
18. Tramadol hydrochloride/montmorillonite composite: preparation and controlled drug release10.1016/j.clay.2010.04.011 ↗
19. Poly(d,l-lactide-co-glycolide)/montmorillonite nanoparticles for oral delivery of anticancer drugs10.1016/j.biomaterials.2005.03.021 ↗
20. Preparation and evaluation of a new nano pharmaceutical excipients and drug delivery system based in polyvinylpyrrolidone and silicates10.18433/J3HC72 ↗
21. Adsorption of organic water pollutants by clays and clay minerals composites: a comprehensive review10.1016/j.clay.2022.106686 ↗
22. Physical and chemical characterization and method for the decontamination of clays for application in cosmetics10.1016/j.clay.2016.02.022 ↗
23. Poly(lactide)–vitamin E derivative/montmorillonite nanoparticle formulations for the oral delivery of Docetaxel10.1016/j.biomaterials.2009.02.045 ↗
24. Influence of exchangeable cation of smectite on HDTMA adsorption: equilibrium, kinetic and thermodynamic studies10.1016/j.clay.2011.11.011 ↗
25. Solid-state intercalation of cationic surfactants into Tunisian smectites10.1180/claymin.2013.048.5.02 ↗
26. Kaolinite group minerals: applications in cancer diagnosis and treatment10.1016/j.ejpb.2020.07.030 ↗
27. Burial diagenetic processes and clay mineral formation in the Molasse zone of upper Austria10.1346/CCMN.1998.0460606 ↗
28. Synthesis the montmorillonite- pomegranate (Punica granatum L.) peel polyphenols nanostructure as a drug delivery vehicle10.13005/bpj/950 ↗
29. Clay mineral/polymer composite: characteristics, synthesis, and application in Li-ion batteries: a review10.1016/j.clay.2022.106632 ↗
30. Accurate description of van der Waals complexes by density functional theory including empirical corrections10.1002/jcc.20078 ↗
31. Semiempirical GGA-type density functional constructed with a long-range dispersion correction10.1002/jcc.20495 ↗
32. Organoclay applications and limits in the environment10.1016/j.crci.2018.09.004 ↗
33. Retention and selectivity of phosphate and fluoride from single and industrial aqueous solutions using purified and surfactant modified Tunisian clay10.5004/dwt.2021.26814 ↗
34. Batch lead(II) removal from aqueous solution by peat10.1205/095758299529983 ↗
35. Heavy metal retention by organoclays: synthesis, applications, and retention mechanism10.1021/cm050754i ↗
36. Structure and nonlinear optical properties study of 2-amino-5-chlorobenzophenone: (a spectroscopic approach)10.13005/ojc/320172 ↗
37. Montmorillonite as a drug delivery system: Intercalation and in vitro release of timolol maleate10.1016/j.ijpharm.2009.03.004 ↗
38. Influence of the organic complex concentration on adsorption of herbicide in organic modified montmorillonite10.1080/03601234.2017.1281636 ↗
39. Magnetite nanoparticles with surface modification for removal of methyl violet from aqueous solutions10.1016/j.arabjc.2011.04.012 ↗
40. Mechanisms of solute release from porous hydrophilic polymers10.1016/0378-5173(83)90064-9 ↗
41. From ultrasoft pseudopotentials to the projector augmented-wave method10.1103/PhysRevB.59.1758 ↗
42. Lagergren · 1898 · 1
43. Baseline studies of the clay minerals society source clays: infrared methods10.1346/CCMN.2001.0490508 ↗
44. Preparation of novel pH-sensitive nanocomposites based on ionic-liquid modified montmorillonite for colon specific drug delivery system10.1002/pc.23169 ↗
45. Kinetic models for the release of the anticancer drug doxorubicin from biodegradable polylactide/metal oxide-based hybrids10.1016/j.ijbiomac.2014.10.038 ↗
46. Investigation on the effect of sintering temperature on kaolin hollow fibre membrane for dye filtration10.1007/s11356-017-9341-6 ↗
47. Clay minerals: Properties and applications to dermocosmetic products and perspectives of natural raw materials for therapeutic purposes—a review10.1016/j.ijpharm.2017.10.031 ↗
48. Effect of cationic surfactant HDPy+ on the acidity and hydrophilicity of Tunisian clay10.1016/j.matchemphys.2018.12.098 ↗
49. Estimation of the point of zero charge of simple oxides by mass titration10.1016/0021-9797(89)90086-6 ↗
50. Simultaneous sorption of benzene and heavy metals onto two organoclays10.1016/j.jcis.2006.10.001 ↗
51. Effect of sulphuric acid treatment on the physico-chemical characteristics of kaolin clay10.1016/j.colsurfa.2010.04.022 ↗
52. Influence of the structure and experimental surfaces modifications of 2:1 clay minerals on the adsorption properties of methylene blue10.3390/min8080359 ↗
53. Controlled release of donepezil intercalated in smectite clays10.1016/j.ijpharm.2008.04.012 ↗
54. Generalized gradient approximation made simple10.1103/PhysRevLett.77.3865 ↗
55. Studies on organic single crystal: 2-amino-5-chlorobenzophenone (2A-5CB)10.1016/j.jcrysgro.2004.01.048 ↗
56. Tl(I) adsorption behavior on K-illite and on humic acids10.1016/j.apgeochem.2022.105220 ↗
57. Clay minerals-based drug delivery systems for anti-tuberculosis drugs
58. Identification of microfabric of kaolinite clay mineral using X-ray diffraction technique10.1007/s10706-007-9133-8 ↗
59. Physicochemical study of the interaction of montmorillonite with hydralazine hydrochloride, a cardiovascular drug10.1016/0169-1317(88)90005-1 ↗
60. Improved grid-based algorithm for Bader charge allocation10.1002/jcc.20575 ↗
61. Synthesis, growth of organic nonlinear optical crystal: semicarbazone of 2-amino-5-chloro-benzophenone (S2A5CB) and its characterisation10.1016/j.jcrysgro.2006.01.038 ↗
62. Green clay ceramics as potential nanovehicles for drug delivery applications10.1016/j.ceramint.2021.08.090 ↗
63. TiO2/Kaolin composite as low-cost adsorbent for procion red removal from aqueous solution: kinetics, equilibrium, and thermodynamic studies10.4314/bcse.v33i3.5 ↗
64. Host-guest interaction between swelling clay minerals and poorly water-soluble drugs. 1: complex formation between a swelling clay mineral and griseofulvin10.1007/BF01066211 ↗
65. Thermal treatment of kaolin: effect on the pozzolanic activity10.1016/j.mspro.2012.06.046 ↗
66. Enrofloxacin uptake and retention on different types of clays10.1016/j.jseaes.2013.02.032 ↗
67. Evaluation of the medicinal use of clay minerals as antibacterial agents10.1080/00206811003679737 ↗
68. Changes in the surfaces of adsorbed para-nitrophenol on HDTMA organoclay—the XRD and TG study10.1016/j.jcis.2006.11.016 ↗